SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Be Quick who wrote (606167)8/26/2016 4:56:42 PM
From: DewDiligence_on_SI1 Recommendation

Recommended By
bentway

  Read Replies (1) of 793669
 
...what specifically in this link that you've provided makes you feel all warm and happy about the FDA wrt the generic EpiPen application?
Nothing—that isn't my point at all. Rather, my point is that lots of applications for both branded and generic drugs get rejected by the FDA for various reasons relating to relatively minor deficiencies in the dossier.

Thus, there's no compelling reason to think the FDA's participation in some kind of conspiracy with the Clinton Foundation (or anyone else) was the impetus for rejecting Teva's generic EpiPen, which is the allegation that started this thread.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News